The Importance of an Early and Accurate MEN1 Diagnosis

by Joanne M. de Laat, Rachel S. van Leeuwaarde, Gerlof D. Valk
Published 2018-09-01

‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1

by Dirk-Jan van Beek, Rachel S van Leeuwaarde, Carolina R C Pieterman, Menno R Vriens, Gerlof D Valk
Published 2018-10-01

Clinical Relevance of Genetic Analysis in Patients With Pituitary Adenomas: A Systematic Review

by Medard F. M. van den Broek, Bernadette P. M. van Nesselrooij, Annemarie A. Verrijn Stuart, Rachel S. van Leeuwaarde, Gerlof D. Valk
Published 2019-12-01

Blood Transcript Profiling for the Detection of Neuroendocrine Tumors: Results of a Large Independent Validation Study

by Mark J. C. van Treijen, Mark J. C. van Treijen, Catharina M. Korse, Catharina M. Korse, Rachel S. van Leeuwaarde, Rachel S. van Leeuwaarde, Lisette J. Saveur, Lisette J. Saveur, Menno R. Vriens, Menno R. Vriens, Wieke H. M. Verbeek, Wieke H. M. Verbeek, Margot E. T. Tesselaar, Margot E. T. Tesselaar, Gerlof D. Valk, Gerlof D. Valk
Published 2018-12-01